GlobeNewsWire · SLIM · October 13, 2026

Rhythm Pharmaceuticals Announces Commercial Launch of IMCIVREE® (setmelanotide) in Japan for Patients with Acquired Hypothalamic Obesity

Get the app for more

Explore stock news, insights and company research.